L500-0455 Screening compound: 1-(1-{[4-(5-ethyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-2,3-dihydro-1H-indole

L500-0455 Screening compound: 1-(1-{[4-(5-ethyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-2,3-dihydro-1H-indole
L500-0455 Screening compound: 1-(1-{[4-(5-ethyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-2,3-dihydro-1H-indole alternative view

Chemical Structure Depiction of ChemDiv screening compound L500-0455
1-(1-{[4-(5-ethyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-2,3-dihydro-1H-indole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L500-0455

Molecular Formula

C22H24N4O4S2 (C22 H24 N4 O4 S2)

Compound Name

1-(1-{[4-(5-ethyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-2,3-dihydro-1H-indole

IUPAC name

1-(1-{[4-(5-ethyl-124-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}piperidine-4-carbonyl)-23-dihydro-1H-indole

SMILES

CCc1nc(-c2csc(S(N(CC3)CCC3C(N(CC3)c4c3cccc4)=O)(=O)=O)c2)no1

InChI

InChI=1S/C22H24N4O4S2/c1-2-19-23-21(24-30-19)17-13-20(31-14-17)32(28,29)25-10-7-16(8-11-25)22(27)26-12-9-15-5-3-4-6-18(15)26/h3-6,13-14,16H,2,7-12H2,1H3

InChI Key

ALUGSPFMTJHQMZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27458485

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.795

Distribution Coefficient, logD

3.795

Water Solubility, LogSw

-3.86

Polar Surface Area

79.990

Acid Dissociation Constant (pKa)

21.79

Base Dissociation Constant (pKb)

0.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

L500-0455 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with L500-0455 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L500-0455?
Check Price and Availability of L500-0455, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L500-0455 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L500-0455
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L500-0455
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L500-0455 available by request